{
    "root": "66eb82f8-6755-42aa-b20c-192a640e8068",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DEXTROSE",
    "value": "20240809",
    "ingredients": [
        {
            "name": "DEXTROSE MONOHYDRATE",
            "code": "LX22YL083G"
        }
    ],
    "indications": "dextrose injection indicated source water calories .",
    "contraindications": "• intravenous infusion . ( 2.1 ) • full prescribing information information preparation , , dosing considerations instructions . ( 2.1 , 2.2 , 2.3 )",
    "warningsAndPrecautions": "dextrose injection , usp clear , colorless , sterile solutions dextrose supplied viaflo dripless access containers ( dac ) non-dac plastic containers shown . viaflo dac drip spike removed . viaflo non-dac drip spike removed port . product description size code ndc dextrose injection 5 % , usp ( 0.05 grams/ml ) 50ml ( dac ) 50ml ( non-dac ) 100ml ( dac ) 100ml ( non-dac ) 250 ml ( dac ) 250 ml ( non-dac ) 500 ml ( dac ) 500 ml ( non-dac ) 1000 ml ( dac ) 1000 ml ( non-dac ) 1000ml ( dac ) ue0086dg ue0086g ue0087dg ue0087g ue0062d ue0062 ue0063d ue0063 ue0064d ue0064 ue0064dg 0338-9651-75 0338-9649-75 0338-9655-60 0338-9653-60 0338-0062-30 0338-0074-30 0338-0066-20 0338-0078-20 0338-0070-10 0338-0082-10 0338-0070-12 remove container overwrap intended . product immediately mixing introduction additives . exposure pharmaceutical products heat minimized . avoid excessive heat . recommended product stored room temperature ( 25°c/77°f ) ; brief exposure 40°c/104°f adversely affect product .",
    "adverseReactions": "dextrose injection contraindicated patients : • clinically significant hyperglycemia [ ( 5.1 ) ] . • known hypersensitivity dextrose [ ( 5.2 ) ] .",
    "indications_original": "Dextrose Injection is indicated as source of water and calories.",
    "contraindications_original": "• Only for intravenous infusion. ( 2.1 ) • See full prescribing information for information on preparation, administration, dosing considerations and instructions for use. ( 2.1 , 2.2 , 2.3 )",
    "warningsAndPrecautions_original": "Dextrose Injection, USP are clear, colorless, sterile solutions of dextrose supplied in VIAFLO dripless access containers (DAC) and non-DAC plastic containers are shown below.  VIAFLO DAC will not drip once the spike is removed.  VIAFLO non-DAC will drip once the spike is removed from the administration port.\n                  \n                     \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Product Description\n                              \n                           \n                           \n                              \n                                 Size\n                              \n                           \n                           \n                              \n                                 Code\n                              \n                           \n                           \n                              \n                                 NDC\n                              \n                           \n                        \n                        \n                           \n                              Dextrose Injection 5%, USP(0.05 grams/mL)\n                           \n                           \n                              50mL (DAC)\n                              50mL (Non-DAC)\n                              100mL (DAC)\n                              100mL (Non-DAC)\n                              250 mL (DAC)\n                              250 mL (Non-DAC)\n                              500 mL (DAC)\n                              500 mL (Non-DAC)\n                              1000 mL (DAC)\n                              1000 mL (Non-DAC)\n                              1000mL (DAC)\n                           \n                           \n                              UE0086DG\n                              UE0086G\n                              UE0087DG\n                              UE0087G\n                              UE0062D\n                              UE0062\n                              UE0063D\n                              UE0063\n                              UE0064D\n                              UE0064\n                              UE0064DG\n                           \n                           \n                              0338-9651-75\n                              0338-9649-75\n                                       0338-9655-60\n                              0338-9653-60\n                              0338-0062-30\n                              0338-0074-30\n                              0338-0066-20\n                              0338-0078-20\n                              0338-0070-10\n                              0338-0082-10\n                              0338-0070-12\n                           \n                        \n                     \n                  \n                  Do not remove container from the overwrap until intended for use.\n                  Use the product immediately after mixing and the introduction of additives.\n                  \n                     Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C/77°F); brief exposure up to 40°C/104°F does not adversely affect the product.",
    "adverseReactions_original": "The use of Dextrose Injection is contraindicated in patients with:\n                  \n                     \n                        •\n                        Clinically significant hyperglycemia [see Warnings and Precautions (5.1)\n                           ].\n                     \n                     \n                        •\n                        Known hypersensitivity to dextrose [see Warnings and Precautions (5.2)\n                           ]."
}